Note: Ingredients listed on restricted chemical lists
EC/CAS
200-338-0/57-55-6
Name of the chemical
1,2-propanediol
Concentration
< 3
EC/CAS
202-859-9/100-51-6
Name of the chemical
Benzyl Alcohol
Concentration
N/A
EC/CAS
9004-64-2
Name of the chemical
hydroxypropylcellulose
Concentration
≤ 1
EC/CAS
203-049-8/102-71-6
Name of the chemical
triethanolamine
Concentration
≤1 64-67
General Information
Revision date
2020-06-10
Product name
PAZOPANIB TOPICAL GEL AND PLACEBO
Product Synonyms
PAZOPANIB TOPICAL GEL 0,1, 0,5, 1 AND 2%W/W AND PLACEBO * GW786034 TOPICAL GEL
Emergency telephone
VERISK 3E GLOBAL INCIDENT RESPONSE
Icons in SDS
Company Information
company name
GlaxoSmithKline UK
e-mail address of the competent person responsible for the Safety Data Sheet
msds@gsk.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H373
Hazard statements
Code
Statements
H373
May cause damage to organs through prolonged or repeated exposure
Section 2
EU Classification
Regulation (EC) No 1272/2008 as amended This mixture does not meet the criteria for classification according to Regulation (EC) 1272/2008 as amended.
Health hazards
Specific target organ toxicity - repeated Category 2 H373 - May cause damage to exposure organs through prolonged or repeated exposure. Hazard summary Caution - Pharmaceutical agent. May cause damage to organs through prolonged or repeated exposure. See section 11 of the SDS for additional information on health hazards.
2.2 Label elements
Label according to Regulation (EC) No. 1272/2008 as amended
Contains
HYDROXYPROPYL CELLULOSE, PAZOPANIB HYDROCHLORIDE, Propylene glycol, Triethanolamine
Signal word
Warning
Hazard statements
H373 May cause damage to organs through prolonged or repeated exposure.
Prevention
P260 Do not breathe mist/vapours.
Response
P314 Get medical advice/attention if you feel unwell.
Storage
Not available.
Disposal
P501 Dispose of contents/container (in accordance with related regulations).
Supplemental label elements
1 % of the mixture consists of component(s) of unknown acute oral toxicity. 5,16 % of the mixture consists of component(s) of unknown acute dermal toxicity. 2 % of the mixture consists of component(s) of unknown acute hazards to the aquatic environment. 2 % of the mixture consists of component(s) of unknown long-term hazards to the aquatic environment.
2.3 Other hazards
This material is non-flammable. Caution - Pharmaceutical agent. See section 11 of the SDS for additional information on health hazards.
